Andrew Retter
CIK 2015252 · Chief Medical Officer · last filed 2025-11-04
Andrew Retter is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider had shares withheld for taxes covering $2.0K of VNRX on Nov 4, 2025. Current disclosed insider exposure totals $5.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.7K
1
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VNRX | Chief Medical Officer | 7,328 | $0.78 | $5.7K | $0 | 11 | 2025-11-04 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-04 | VNRX | Tax (F) | −4,588 | -$2.0K | EDGAR |
| 2025-08-19 | VNRX | Grant (A) | +19,524 | $0 | EDGAR |
| 2025-08-05 | VNRX | Tax (F) | −6,142 | -$3.9K | EDGAR |
| 2025-07-03 | VNRX | Tax (F) | −4,401 | -$3.4K | EDGAR |
| 2025-06-03 | VNRX | Mixed | +8,471 | -$2.3K | EDGAR |
| 2025-05-05 | VNRX | Tax (F) | −3,913 | -$1.9K | EDGAR |
| 2025-03-04 | VNRX | Grant (A) | +10,142 | $0 | EDGAR |
| 2024-12-03 | VNRX | Grant (A) | +9,365 | $0 | EDGAR |
| 2024-09-04 | VNRX | Grant (A) | +9,784 | $0 | EDGAR |
| 2024-06-04 | VNRX | Grant (A) | +8,326 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.